Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia

Annals of Hematology

Volumn 87, Issue 11, 2008, Pages 887-890

  Sommer, Constanze ^a   Lackner, Herwig ^a   Benesch, Martin ^a   Sovinz, Petra ^a   Schwinger, Wolfgang ^a   Moser, Andrea ^a   Bergloeff, Jutta ^a   Gruber, Anna ^a   Urban, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Acute myeloid leukaemia; Intrathecal chemotherapy; Liposomal cytarabine; Neuroophthalmological side effects

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; LIPOSOME; PREDNISOLONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARACHNOIDITIS; ARTICLE; CASE REPORT; CAUDA EQUINA SYNDROME; CENTRAL NERVOUS SYSTEM; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DIPLOPIA; DISEASE SEVERITY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG RESPONSE; DRUG WITHDRAWAL; EYE EXAMINATION; FEMALE; HUMAN; INFLAMMATORY INFILTRATE; INTRAOCULAR HEMORRHAGE; LEUKEMIA REMISSION; LIPOSOMAL DELIVERY; LONG TERM CARE; LOW BACK PAIN; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; MULTIPLE CYCLE TREATMENT; NEUROOPHTHALMOLOGY; OPHTHALMOSCOPY; PAPILLEDEMA; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; SWELLING;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIMETABOLITES, ANTINEOPLASTIC; CYTARABINE; DEXAMETHASONE; FEMALE; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, MYELOID, ACUTE; LIPOSOMES; MALE; PAPILLEDEMA; REMISSION INDUCTION;

EID: 53549095194     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0521-9     Document Type: Article

References (12)

1. Benesch M, Sovinz P, Krammer B, Lackner H, Mann G, Schwinger W et al (2007) Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis. J Pediatr Hematol Oncol 29:222-226 doi: 10.1097/MPH.0b013e318041f112
2. Bomgaars L, Geyer JR, Franklin J, Dahl G, Park J, Winick NJ et al (2004) Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. J Clin Oncol 22:3916-3921 doi: 10.1200/ JCO.2004.01.046
3. Chamberlain MC, Glantz MJ (2007) Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphatic leukaemia. Blood 110:1698 author reply 1698-1699 doi: 10.1182/blood-2007-02-073536
4. Chamberlain MC, Kormanik P, Howell SB, Kim S (1995) Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol 52:912-917
5. Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G et al (2005) Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 19:2030-2042 doi: 10.1038/sj.leu.2403920
6. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T (2004) Early deaths and treatment related mortality in children undergoing therapy for acute myeloid leukaemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 22:4384-4393 doi: 10.1200/JCO.2004.01.191
7. Glantz MJ, La Folette S, Jaeckle KA, Shapiro W, Swinnen L, Rozental JR et al (1999) Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol 17:3110-3116
8. Goshen Y, Stark B, Kornreich L, Michowiz S, Feinmesser M, Yaniv I (2007) High incidence of meningioma in cranial irradiated survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 49:294-297 doi: 10.1002/pbc.21153
9. Hata M, Ogino I, Aida N, Saito K, Omura M, Kigasawa H et al (2001) Prophylactic cranial irradiation of acute lymphoblastic leukemia in childhood: Outcomes of late effects on pituitary function and growth in long-term survivors. Int J Cancer 96(Suppl):117-124 doi: 10.1002/ ijc.10348
10. Jabbour E, O'Brien S, Kantarjian H, Garcia-Manero G, Ferrajoli A, Ravandi F et al (2007) Neurological complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood 109:3214-3218 doi: 10.1182/ blood-2006-08-043646
11. McClune B, Buadi FK, Aslam N, Przepiorka D (2007) Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukaemia and high-grade lymphoma. Leuk Lymphoma 48:1849-1851 doi: 10.1080/10428190701573232
12. Pui C-H (2007) Toward optimal use of intrathecal liposomal cytarabine. Leuk Lymphoma 48:1672-1673 doi: 10.1080/10428190701573687